Patient registries: EMA officials highlight opportunities in orphan drug development
Regulatory NewsFerdous Al-Faruque
BiologicsBiotechnologyClinical TrialsCombination ProductsDiagnosticsEuropeMedical DevicesOtherPharmaceuticalsPreclinical studyProduct LifecycleRegulatory Intelligence/PolicyResearch, Design and Development